deltatrials
Completed PHASE3 NCT00003317

Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Stage IIIA Non-small Cell Lung Cancer

A Phase III Study of Surgical Resection and Chemotherapy (Paclitaxel and Carboplatin) With or Without Adjuvant Radiotherapy for Resected Stage IIIA Non-Small Cell Lung Cancer

Sponsor: Alliance for Clinical Trials in Oncology

Conditions Lung Cancer
Interventions carboplatin paclitaxel radiation therapy surgery
Updated 5 times since 2017 Last updated: Jul 12, 2016 Started: May 31, 1998 Primary completion: Jun 30, 2005 Completion: Aug 31, 2005

Listed as NCT00003317, this PHASE3 trial focuses on Lung Cancer and remains completed. Sponsored by Alliance for Clinical Trials in Oncology, it has been updated 5 times since 1998, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE3

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE3

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE3

    First recorded

May 1998

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Alliance for Clinical Trials in Oncology
  • National Cancer Institute (NCI)
Data source: Alliance for Clinical Trials in Oncology

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Bismarck, United States, Cedar Rapids, United States, Des Moines, United States, Duluth, United States, Fargo, United States, Grand Forks, United States, Omaha, United States, Peoria, United States, Rapid City, United States, Rochester, United States and 6 more location s